May 9, 2017 • 4:15 PM EDT

Q1 2017 Quarterly Results

Quarter Ended Mar 31, 2017

Latest 10-K

View Latest 10-K

Stock Information

Symbol

NYSE MKT: NAVB

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.

Investor Contact Information

Navidea Biopharmaceuticals, Inc.

4995 Bradenton Avenue
Suite 240
Dublin, OH 43017

Investor Relations

Jed Latkin
Chief Financial and Operating Officer
T: 614-973-7490
jlatkin@navidea.com